Internal Medicine · Bowling Green, KY
NPI
1578569984
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
201 Park St
Bowling Green, KY, 42101
Phone (270) 781-5111
Groups this clinician bills Medicare through
Medicare paid, 2024
$448K
41,938 services
Medicare patients, 2024
624
Average age 76
Drug cost, 2024
$3.2M
29,594 prescriptions
Company payments, 2025
$1,666
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sherryl Reed was code J0897 (injection, denosumab, 1 mg), 4,560 times for 47 patients. In total Sherryl Reed billed 41,938 services in 223 codes, and Medicare paid $448K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,560 | 47 | $19.84 | $90K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 3,325 | 27 | $0.10 | $320 |
| A9575 Injection, gadoterate meglumine, 0.1 ml | Office | 1,740 | 12 | $0.09 | $159 |
| 80048 Clinical Chemistry | Office | 998 | 428 | $8.26 | $8,247 |
| 99214 Office E&M - Established | Office | 952 | 386 | $76.32 | $73K |
| 80061 Clinical Chemistry | Office | 820 | 414 | $13.05 | $11K |
| 80076 Clinical Chemistry | Office | 775 | 393 | $7.97 | $6,180 |
| 83036 Blood Count | Office | 757 | 402 | $9.50 | $7,189 |
| 85025 Blood Count | Office | 691 | 337 | $7.59 | $5,244 |
| 84443 Clinical Chemistry | Office | 521 | 304 | $16.44 | $8,564 |
| 96372 Injection Administration | Office | 388 | 128 | $8.93 | $3,465 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 381 | 381 | $123.02 | $47K |
| 83721 Clinical Chemistry | Office | 257 | 202 | $10.16 | $2,612 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 248 | 26 | $0.66 | $164 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 222 | 51 | $0.80 | $177 |
By year: 2022 $385K for 19,895 services; 2023 $386K for 32,334 services; 2024 $448K for 41,938 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80048 Clinical Chemistry | 998 | 428 | $8.26 | $8,247 |
| 80061 Clinical Chemistry | 820 | 414 | $13.05 | $11K |
| 80076 Clinical Chemistry | 775 | 393 | $7.97 | $6,180 |
| 83036 Blood Count | 757 | 402 | $9.50 | $7,189 |
| 85025 Blood Count | 691 | 337 | $7.59 | $5,244 |
| 84443 Clinical Chemistry | 521 | 304 | $16.44 | $8,564 |
| 83721 Clinical Chemistry | 257 | 202 | $10.16 | $2,612 |
| 82043 Clinical Chemistry | 162 | 109 | $5.66 | $917 |
| 82728 Clinical Chemistry | 161 | 100 | $13.36 | $2,151 |
| 82570 Clinical Chemistry | 159 | 109 | $5.08 | $808 |
Medicare prescription drug claims, 2024
In 2024, the drug Sherryl Reed prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,252 prescriptions and refills. In total Sherryl Reed wrote 29,594 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,252 | 2,599 | 256 | $11K |
| Atorvastatin Calcium Generic | 969 | 2,057 | 202 | $7,477 |
| Amlodipine Besylate Generic | 964 | 1,907 | 208 | $4,437 |
| Rosuvastatin Calcium Generic | 905 | 1,880 | 213 | $11K |
| Pantoprazole Sodium Generic | 807 | 1,531 | 167 | $8,366 |
| Furosemide Generic | 605 | 1,017 | 138 | $2,811 |
| Potassium Chloride Generic | 585 | 1,058 | 129 | $12K |
| Gabapentin Generic | 560 | 678 | 101 | $5,758 |
| Losartan Potassium Generic | 529 | 1,089 | 117 | $4,964 |
| Escitalopram Oxalate Generic | 496 | 908 | 111 | $4,111 |
| Omeprazole Generic | 487 | 1,019 | 101 | $5,787 |
| Carvedilol Generic | 475 | 884 | 95 | $4,134 |
| Metoprolol Tartrate Generic | 474 | 1,005 | 105 | $2,262 |
| Hydrochlorothiazide Generic | 471 | 997 | 106 | $1,859 |
| Metoprolol Succinate Generic | 464 | 945 | 102 | $7,022 |
Brand drugs: 3,931 claims; generic drugs: 25,426 claims; opioid claims: 905.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sherryl Reed $1,666 ($1,666 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $213.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $213 |
| GlaxoSmithKline, LLC. GSK | 10 | $180 |
| Abbvie Inc. ABBV | 18 | $172 |
| Sumitomo Pharma America, Inc. 4506.T | 10 | $162 |
| Pfizer Inc. PFE | 11 | $149 |
| Amgen Inc. AMGN | 11 | $141 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $80.02 |
| Lilly USA, LLC LLY | 5 | $73.3 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $71.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.